Pioneering New Treatments for Chronic Eye Diseases
Our focus is to develop and lead the global ophthalmic market with novel therapies that advance the existing standard of care.
Scroll DownOur Stats
-
#1
Pioneer of micro-invasive glaucoma surgery (MIGS)
-
1,500+
Employees globally
-
3.5m+
Eyes treated with our products globally
-
20+
Countries with commercial presence worldwide
Glaukos pioneers breakthrough therapies that are reshaping eye care and preserving vision across global communities.
Ophthalmic InnovationWhere We Lead
Glaukos is pioneering pharmaceutical innovation, advanced device engineering, and procedural expertise into cohesive therapeutic platforms.
-
Cornea
Cross-linking intervention to slow or halt progressive keratoconus to help preserve patients' vision.
View Therapies -
Glaucoma
Market-leading portfolio of innovative glaucoma therapies.
View Therapies -
Retina
Developing sustained-release drug delivery platforms for retinal diseases.
View Therapies
Advancing the future of vision care through bold innovation and scientific excellence, guided by strong leadership at every step.
Executive Team
Company News & Updates
-
-
Glaukos Announces Second Quarter 2026 Financial Results
-
Glaukos Announces Completion of Patient Enrollment in 510(k) Pivotal Study for PRESERFLO™ MicroShunt
-
Glaukos to Release Second Quarter 2026 Financial Results after Market Close on July 29
-
Glaukos Announces Completion of Patient Enrollment in Phase 2 Study of GLK-321 for Demodex Blepharitis
-
Glaukos Announces Participation in Upcoming Investor Conferences
Clinical Resources
A centralized hub for product details, procedural insights, and practical tools that align with real world clinical workflows
-
Physician Resources
Curated presentations and data from leading experts, showcasing the latest advancements and clinical evidence
Physicians Portal -
Clinical Presentations
Curated presentations and data from leading experts, showcasing the latest advancements and clinical evidence
View Presentations -
Coverage and Reimbursement
Documents provide assistance for FDA-approved or cleared indications.
Reimbursement Resources
Advancing the Future of Vision Care
Glaukos is redefining how eye diseases are treated through innovation across pharmaceuticals and medical technology.
Explore Our Story-
Our Journey
From pioneering micro-invasive glaucoma surgery to expanding across cornea and retina, our history is defined by bold innovation and category leadership.
View Timeline -
Giving Back
We’re committed to expanding access to vision care and supporting communities through meaningful philanthropy and global outreach.
See Our Impact -
Recognition
Our work continues to be recognized across the industry for innovation, clinical impact, and leadership in advancing eye care.
View Achievements
A Place to Grow, Lead, and Thrive
-
Purpose-Driven Work
Every role contributes to advancing vision care—bringing innovative treatments to patients worldwide.
-
Built for Builders
Small, empowered teams solving complex problems with real ownership and speed.
-
Innovation with Impact
Work on breakthrough therapies that redefine how ocular diseases are treated.
-
Life at Glaukos
A culture grounded in trust, flexibility, and support—so people can do their best work.
-
90%+
Employee retention driven by strong culture and career growth
-
4.5
Average employee satisfaction rating across workplace platforms
-
25+
Years of innovation shaping the future of ophthalmology